Ping‐Hui Tseng

3.9k total citations
36 papers, 3.2k citations indexed

About

Ping‐Hui Tseng is a scholar working on Molecular Biology, Immunology and Cancer Research. According to data from OpenAlex, Ping‐Hui Tseng has authored 36 papers receiving a total of 3.2k indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Molecular Biology, 16 papers in Immunology and 9 papers in Cancer Research. Recurrent topics in Ping‐Hui Tseng's work include Immune Response and Inflammation (12 papers), NF-κB Signaling Pathways (8 papers) and PI3K/AKT/mTOR signaling in cancer (6 papers). Ping‐Hui Tseng is often cited by papers focused on Immune Response and Inflammation (12 papers), NF-κB Signaling Pathways (8 papers) and PI3K/AKT/mTOR signaling in cancer (6 papers). Ping‐Hui Tseng collaborates with scholars based in Taiwan, United States and United Kingdom. Ping‐Hui Tseng's co-authors include Michael Karin, Dario A.A. Vignali, Atsushi Matsuzawa, Hans Häcker, Ching-Shih Chen, Haopeng Wang, Weizhou Zhang, Sivakumar Vallabhapurapu, Ya-Ting Yang and Jonathan J. Keats and has published in prestigious journals such as Science, Proceedings of the National Academy of Sciences and Journal of Biological Chemistry.

In The Last Decade

Ping‐Hui Tseng

36 papers receiving 3.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Ping‐Hui Tseng Taiwan	25	1.7k	1.3k	871	512	312	36	3.2k
Jugnu Jain United States	21	2.8k 1.6×	1.6k 1.2×	856 1.0×	722 1.4×	120 0.4×	38	4.2k
Susan R. Pfeffer United States	24	2.4k 1.4×	1.2k 0.9×	1.5k 1.8×	1.0k 2.0×	128 0.4×	34	4.0k
Raymond Davis United States	9	1.4k 0.8×	967 0.7×	755 0.9×	1.1k 2.1×	129 0.4×	12	3.5k
Renate Hofer-Warbinek Austria	24	1.8k 1.1×	859 0.7×	627 0.7×	554 1.1×	114 0.4×	35	3.1k
Matthew Brook United Kingdom	17	1.7k 1.0×	628 0.5×	636 0.7×	494 1.0×	325 1.0×	20	2.6k
Young Joo Jeon South Korea	36	2.3k 1.3×	806 0.6×	1.0k 1.2×	501 1.0×	163 0.5×	119	3.8k
Hiroaki Takimoto Japan	30	1.5k 0.9×	1.7k 1.3×	288 0.3×	436 0.9×	177 0.6×	85	3.7k
Shanchun Guo United States	24	1.4k 0.8×	649 0.5×	540 0.6×	851 1.7×	85 0.3×	78	3.1k
Takahisa Sugita Japan	21	1.9k 1.1×	1.6k 1.2×	1.3k 1.5×	1.0k 2.0×	133 0.4×	55	4.0k
Dai‐Wu Seol United States	23	2.1k 1.2×	680 0.5×	570 0.7×	471 0.9×	86 0.3×	39	2.9k

Countries citing papers authored by Ping‐Hui Tseng

Since Specialization

Citations

This map shows the geographic impact of Ping‐Hui Tseng's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ping‐Hui Tseng with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ping‐Hui Tseng more than expected).

Fields of papers citing papers by Ping‐Hui Tseng

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ping‐Hui Tseng. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ping‐Hui Tseng. The network helps show where Ping‐Hui Tseng may publish in the future.

Co-authorship network of co-authors of Ping‐Hui Tseng

This figure shows the co-authorship network connecting the top 25 collaborators of Ping‐Hui Tseng. A scholar is included among the top collaborators of Ping‐Hui Tseng based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ping‐Hui Tseng. Ping‐Hui Tseng is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Chu, Pen‐Yuan, et al.. (2025). The Hedgehog Pathway Promotes Monocytes Infiltration Through CCL20 – CCR6 Axis in Hepatocellular Carcinoma. Journal of Cellular and Molecular Medicine. 29(17). e70824–e70824. 1 indexed citations

Jeng, Kuo‐Shyang, et al.. (2023). Aldo-keto reductase family member C3 (AKR1C3) promotes hepatocellular carcinoma cell growth by producing prostaglandin F2α. Oncology Research Featuring Preclinical and Clinical Cancer Therapeutics. 32(1). 163–174. 7 indexed citations

Cai, Ling, Ta-Hsien Lin, Kou-Juey Wu, et al.. (2021). USP7 facilitates SMAD3 autoregulation to repress cancer progression in p53-deficient lung cancer. Cell Death and Disease. 12(10). 880–880. 24 indexed citations

Chen, I‐Ting, Chung‐Wai Shiau, Chia‐Lin Hsu, et al.. (2017). Suppression of LPS-induced inflammatory responses by the hydroxyl groups of dexamethasone. Oncotarget. 8(30). 49735–49748. 26 indexed citations

Yeh, Da‐Wei, Ping‐Hui Tseng, Chiou‐Hwa Yuh, et al.. (2017). CpG-oligodeoxynucleotides developed for grouper toll-like receptor (TLR) 21s effectively activate mouse and human TLR9s mediated immune responses. Scientific Reports. 7(1). 17297–17297. 27 indexed citations

Chen, I‐Ting, Pang‐Hung Hsu, Wan‐Ching Hsu, Nien‐Jung Chen, & Ping‐Hui Tseng. (2015). Polyubiquitination of Transforming Growth Factor β-activated Kinase 1 (TAK1) at Lysine 562 Residue Regulates TLR4-mediated JNK and p38 MAPK Activation. Scientific Reports. 5(1). 12300–12300. 52 indexed citations

Su, Jung-Chen, Jui-Wen Huang, Ping‐Yu Chen, et al.. (2015). Copper–obatoclax derivative complexes mediate DNA cleavage and exhibit anti-cancer effects in hepatocellular carcinoma. Chemico-Biological Interactions. 228. 108–113. 6 indexed citations

Chang, Yu‐Ling, Ping‐Hui Tseng, Shie‐Liang Hsieh, et al.. (2014). A novel TLR2‐triggered signalling crosstalk synergistically intensifies TNF‐mediated IL‐6 induction. Journal of Cellular and Molecular Medicine. 18(7). 1344–1357. 14 indexed citations

Tseng, Ping‐Hui, Szu‐Hsien Wu, Wei‐Tien Tai, et al.. (2014). SC-2001 Overcomes STAT3-mediated Sorafenib Resistance through RFX-1/SHP-1 Activation in Hepatocellular Carcinoma. Neoplasia. 16(7). 595–605. 43 indexed citations

10.

Liu, Jin, Chuanshan Xu, Jeng‐Fan Lo, et al.. (2012). Activation of rabbit TLR9 by different CpG-ODN optimized for mouse and human TLR9. Comparative Immunology Microbiology and Infectious Diseases. 35(5). 443–451. 17 indexed citations

11.

Zhang, Weizhou, Arnon P. Kater, George F. Widhopf, et al.. (2010). B-cell activating factor and v-Myc myelocytomatosis viral oncogene homolog (c-Myc) influence progression of chronic lymphocytic leukemia. Proceedings of the National Academy of Sciences. 107(44). 18956–18960. 54 indexed citations

12.

Tseng, Ping‐Hui, Atsushi Matsuzawa, Weizhou Zhang, et al.. (2009). Different modes of ubiquitination of the adaptor TRAF3 selectively activate the expression of type I interferons and proinflammatory cytokines. Nature Immunology. 11(1). 70–75. 327 indexed citations

13.

Matsuzawa, Atsushi, Ping‐Hui Tseng, Sivakumar Vallabhapurapu, et al.. (2008). Essential Cytoplasmic Translocation of a Cytokine Receptor–Assembled Signaling Complex. Science. 321(5889). 663–668. 179 indexed citations

14.

Tseng, Ping‐Hui, Yu-Chieh Wang, Jing‐Ru Weng, et al.. (2006). Overcoming Trastuzumab Resistance in HER2-Overexpressing Breast Cancer Cells by Using a Novel Celecoxib-Derived Phosphoinositide-Dependent Kinase-1 Inhibitor. Molecular Pharmacology. 70(5). 1534–1541. 63 indexed citations

15.

Chen, Chang‐Shi, et al.. (2005). Histone Acetylation-independent Effect of Histone Deacetylase Inhibitors on Akt through the Reshuffling of Protein Phosphatase 1 Complexes. Journal of Biological Chemistry. 280(46). 38879–38887. 200 indexed citations

16.

Wu, Jui‐Sheng, Wai-Mui Cheung, Ping‐Hui Tseng, et al.. (2005). Induction of Prostacyclin/PGI₂ Synthase Expression After Cerebral Ischemia–Reperfusion. Journal of Cerebral Blood Flow & Metabolism. 26(4). 491–501. 37 indexed citations

17.

Tseng, Ping‐Hui, Jiuxiang Zhu, Kuen‐Feng Chen, et al.. (2005). Synergistic interactions between imatinib mesylate and the novel phosphoinositide-dependent kinase-1 inhibitor OSU-03012 in overcoming imatinib mesylate resistance. Blood. 105(10). 4021–4027. 52 indexed citations

18.

Zhu, Jiuxiang, Jui-Wen Huang, Ping‐Hui Tseng, et al.. (2004). From the Cyclooxygenase-2 Inhibitor Celecoxib to a Novel Class of 3-Phosphoinositide-Dependent Protein Kinase-1 Inhibitors. Cancer Research. 64(12). 4309–4318. 215 indexed citations

19.

Kulp, Samuel K., Ya-Ting Yang, Chin‐Chun Hung, et al.. (2004). 3-Phosphoinositide-Dependent Protein Kinase-1/Akt Signaling Represents a Major Cyclooxygenase-2-Independent Target for Celecoxib in Prostate Cancer Cells. Cancer Research. 64(4). 1444–1451. 213 indexed citations

20.

Yang, Chih-Cheng, Chang‐Shi Chen, Ya-Ting Yang, et al.. (2003). Bcl-xL Mediates a Survival Mechanism Independent of the Phosphoinositide 3-Kinase/Akt Pathway in Prostate Cancer Cells. Journal of Biological Chemistry. 278(28). 25872–25878. 49 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact